Consainsights logo
  • Reports /
  • Over the Counter (OTC) Analgesics Market

Over the Counter (OTC) Analgesics Market

Over the Counter (OTC) Analgesics Market Market Research Report – Segmented By Type of Drug (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates, Other Analgesics​), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others Distribution Channels) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.

Table of contents

Executive Summary

Over the Counter (OTC) Analgesics Market was valued at US $27,711.15 million in 2021 and is projected to grow at 5.37% CAGR over the forecast period to reach US $37,928.59 million by 2027. Over the Counter (OTC) Analgesics Market represented US $2,752.73 million opportunity over 2019-2021 and estimated to create US $10,217.45 million opportunity in 2027 over 2021.

Over the Counter (OTC) Analgesics Market Size (2019 - 2027), USD million

Over the Counter (OTC) Analgesics from Consainsights analyses the Over the Counter (OTC) Analgesics Market in the Life Sciences industry over the forecast period to 2027.

Over the Counter (OTC) Analgesics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Over the Counter (OTC) Analgesics segmentation includes Type of Drug, Distribution Channel and Geography.

Based on the Type of Drug, the Over the Counter (OTC) Analgesics analysis covers Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates, Other Analgesics​.

In Type of Drug segment, Acetaminophen segment has highest cagr growth of 4.76%.

Revenue Share (%), By Type of Drug (2021)

Based on the Distribution Channel, the Over the Counter (OTC) Analgesics analysis covers Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others Distribution Channels.

In Distribution Channel segment, Hospital Pharmacies segment has highest cagr growth of 4.76%.

Revenue Share (%), By Distribution Channel (2021)

Based on the region, the Over the Counter (OTC) Analgesics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi SA, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Merck & Co Inc., Novartis AG and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type of Drug

Introduction

In 2021, Acetaminophen segment has the highest revenue of US $11,799.07 million and is expected to grow at CAGR of 4.76% by 2027 Acetaminophen segment has highest cagr growth of 4.76%.

Over the Counter (OTC) Analgesics Market Y-o-Y Growth (USD million), By Type of Drug 2019 - 2027
Over the Counter (OTC) Analgesics Market Size, By Type of Drug, 2019-2027 (USD million)

Acetaminophen

Acetaminophen segment was valued at US $10,626.99 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $16,149.54 million by 2027. Acetaminophen segment represented US $1,172.08 million opportunity over 2019-2021 and estimated to create US $4,350.47 million opportunity in 2027 over 2021.

Acetaminophen - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment was valued at US $8,427.72 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $12,807.37 million by 2027. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment represented US $929.51 million opportunity over 2019-2021 and estimated to create US $3,450.13 million opportunity in 2027 over 2021.

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Salicylates

Salicylates segment was valued at US $2,645.70 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $4,020.59 million by 2027. Salicylates segment represented US $291.80 million opportunity over 2019-2021 and estimated to create US $1,083.09 million opportunity in 2027 over 2021.

Salicylates - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Other Analgesics​

Other Analgesics​ segment was valued at US $3,258.01 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $4,951.10 million by 2027. Other Analgesics​ segment represented US $359.33 million opportunity over 2019-2021 and estimated to create US $1,333.76 million opportunity in 2027 over 2021.

Other Analgesics​ - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Distribution Channel

Introduction

In 2021, Hospital Pharmacies segment has the highest revenue of US $11,476.89 million and is expected to grow at CAGR of 4.76% by 2027 Hospital Pharmacies segment has highest cagr growth of 4.76%.

Over the Counter (OTC) Analgesics Market Y-o-Y Growth (USD million), By Distribution Channel 2019 - 2027
Over the Counter (OTC) Analgesics Market Size, By Distribution Channel, 2019-2027 (USD million)

Hospital Pharmacies

Hospital Pharmacies segment was valued at US $10,336.82 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $15,708.57 million by 2027. Hospital Pharmacies segment represented US $1,140.07 million opportunity over 2019-2021 and estimated to create US $4,231.67 million opportunity in 2027 over 2021.

Hospital Pharmacies - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Retail Pharmacies

Retail Pharmacies segment was valued at US $6,572.50 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $9,988.05 million by 2027. Retail Pharmacies segment represented US $724.90 million opportunity over 2019-2021 and estimated to create US $2,690.64 million opportunity in 2027 over 2021.

Retail Pharmacies - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Online Pharmacies

Online Pharmacies segment was valued at US $4,611.03 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $7,007.25 million by 2027. Online Pharmacies segment represented US $508.56 million opportunity over 2019-2021 and estimated to create US $1,887.66 million opportunity in 2027 over 2021.

Online Pharmacies - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Others Distribution Channels

Others Distribution Channels segment was valued at US $3,438.07 million in 2019 and is projected to grow at 4.76% CAGR over the forecast period to reach US $5,224.73 million by 2027. Others Distribution Channels segment represented US $379.19 million opportunity over 2019-2021 and estimated to create US $1,407.47 million opportunity in 2027 over 2021.

Others Distribution Channels - Historical, Forecast Market Sizes (USD million), 2019 - 2027